TrialJournal of clinical pharmacology2026

Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults.

Emma Ilsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.